AG003A8H

Name: N-(5-tert-Butylisoxazol-3-yl)-N'-[4-[7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
Brand: Angene Chemical
SKU: AG003A8H

950769-58-1 | N-(5-tert-Butylisoxazol-3-yl)-N'-[4-[7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea

Chemical structure of N-(5-tert-Butylisoxazol-3-yl)-N'-[4-[7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea, CAS 950769-58-1

AG003A8H

SDS

COA

TIP This product is typically in stock.Please contact us for quotation.

Request For Quotation

CAS Number	950769-58-1
Catalog Number	AG003A8H(AGN-PC-0W4O59)
Chemical Name	N-(5-tert-Butylisoxazol-3-yl)-N'-[4-[7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
IUPAC Name	1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
InChI	InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)
InChI Key	CVWXJKQAOSCOAB-UHFFFAOYSA-N
MDL Number	MFCD18074524
Molecular Formula	C29H32N6O4S
Molecular Weight	560.6672
SMILES	O=C(NC1=CC=C(C2=CN3C(SC4=CC(OCCN5CCOCC5)=CC=C34)=N2)C=C1)NC6=NOC(C(C)(C)C)=C6
UNII	7LA4O6Q0D3
Synonyms	AC220 compound, quizartinib, Quizartinib, 950769-58-1, Quizartinib (AC220), AC220, AC-220, AC 220, UNII-7LA4O6Q0D3, AC 010220, AC010220, 7LA4O6Q0D3, CHEMBL576982, CHEBI:90217, ASP-2689, 1-(5-Tert-Butyl-1,2-Oxazol-3-Yl)-3-(4-{7-[2-(Morpholin-4-Yl)ethoxy]imidazo[2,1-B][1,3]benzothiazol-2-Yl}phenyl)urea, N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, C29H32N6O4S, CHEMBL2386811, 1-(5-(tert-butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea, Quizartinib [USAN:INN], quizartinibum, N-(5-TERT-BUTYLISOXAZOL-3-YL)-N'-[4-[7-(2-MORPHOLIN-4-YLETHOXY)IMIDAZO[2,1-B][1,3]BENZOTHIAZOL-2-YL]PHENYL]UREA, AC220,Quizartinib, Quizartinib, 95%, AC220 - Quizartinib, Quizartinib (USAN/INN), cc-62, Quizartinib, AC010220, SCHEMBL72923, MLS006011240, GTPL5658, KS-00000XGC, DTXSID70241746, SYN1003, CVWXJKQAOSCOAB-UHFFFAOYSA-N, BCPP000443, HMS3244K09, HMS3244K10, HMS3244L09, HMS3265G09, HMS3265G10, HMS3265H09, HMS3265H10, HMS3654J20, AOB87793, API01014, BCP02224, ABP000304, AC220/AC-220, BDBM50300690, MFCD18074524, RS0039, s1526, ZINC43204002, AKOS015891557, BCP9000223, CS-0211, DB12874, SB16610, NCGC00242493-01, NCGC00242493-02, NCGC00242493-07, AK198686, AS-16178, BC659962, HY-13001, QC-11462, SC-85893, SMR004703000, AX8232319, B5858, FT-0687630, SW218131-2, V2458, D09955, J-524214, BRD-K93918653-001-01-4, I14-17017, N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholi, AC-220;AC220;AC 220;950769-58-1, 1-(5-(tert-Butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)-benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea, 3-(5-tert-butyl-1,2-oxazol-3-yl)-1-(4-{10-[2-(morpholin-4-yl)ethoxy]-7-thia-2,5-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(12),3,5,8,10-pentaen-4-yl}phenyl)urea, N-(5-(1,1-Dimethylethyl)isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-yl)ethoxy)imidazo(2,1- b)benzothiazol-2-yl)phenyl)urea, N-(5-(1,1-Dimethylethyl)isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-yl)ethoxy)imidazo(2,1-b)benzothiazol-2-yl)phenyl)urea, N-(5-tert-Butyl-isoxazol-3-yl)-N''-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, N-(5-Tert-butyl-isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-ylethoxy)imidazo(2,1-b) (1,3)benzothiazol-2-yl)phenyl)urea, N-(5-tert-Butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea dihydrochloride, N-(5-tert-Butylisoxazol-3-yl)-N'-[4-[7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea, N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea(Quizartinib), Urea, N-(5-(1,1-dimethylethyl)-3-isoxazolyl)-N'-(4-(7-(2-(4-morpholinyl)ethoxy) imidazo(2,1-b)benzothiazol-2-yl)phenyl)-, Urea,N-[5-(1,1-dimethylethyl)-3-isoxazolyl]-N'-[4-[7-[2-(4-morpholinyl)ethoxy]imidazo[2,1-b]benzothiazol-2-yl]phenyl]-, AC220 compound, Quizartinib [USAN], D07KYT, ITD 1, PLX3397, ACN-037466, A5793, A10027, C544967, 1-METHYLPIPERAZINE-2-CARBOXYLIC ACID DIHYDROCHLORIDE, Quizartinib, 98%, a uniquely potent and selective Flt3 inhibitor - 10MG 10mg, 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea, 1099644-42-4, 1246550-14-0, p30, Urea, N-[5-(1,1-dimethylethyl)-3-isoxazolyl]-N'-[4-[7-[2-(4-morpholinyl)ethoxy]imidazo[2,1-b]benzothiazol-2-yl]phenyl]-,

Complexity	849
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	560.221g/mol
Formal Charge	0
Heavy Atom Count	40
Hydrogen Bond Acceptor Count	8
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	560.673g/mol
Monoisotopic Mass	560.221g/mol
Rotatable Bond Count	8
Topological Polar Surface Area	134A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	5.6

Related Research Chemicals

CERTIFICATE OF ANALYSIS

Chemical Name:	Batch Number:
Chemical Structure:	CAS Registry No:
	Product ID:
	Manufacture Date:
	Storage Temperature:
	Formula:
	Molecular Weight:
	Quantity:

Analysis Data:

Test:

Result:

Conclusion: The above product meets the specifications of Angene.

Analyst:Chase

Date:

Reviewed by:Jessie

Date:

Angene International Limited

Symbol:
Hazard statements
Precautionary statements